全文获取类型
收费全文 | 2139篇 |
免费 | 172篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 111篇 |
妇产科学 | 43篇 |
基础医学 | 240篇 |
口腔科学 | 47篇 |
临床医学 | 184篇 |
内科学 | 389篇 |
皮肤病学 | 27篇 |
神经病学 | 95篇 |
特种医学 | 254篇 |
外科学 | 193篇 |
综合类 | 88篇 |
一般理论 | 1篇 |
预防医学 | 264篇 |
眼科学 | 36篇 |
药学 | 155篇 |
中国医学 | 9篇 |
肿瘤学 | 174篇 |
出版年
2021年 | 24篇 |
2020年 | 15篇 |
2019年 | 21篇 |
2018年 | 27篇 |
2017年 | 17篇 |
2016年 | 21篇 |
2015年 | 33篇 |
2014年 | 65篇 |
2013年 | 96篇 |
2012年 | 72篇 |
2011年 | 70篇 |
2010年 | 57篇 |
2009年 | 76篇 |
2008年 | 64篇 |
2007年 | 93篇 |
2006年 | 73篇 |
2005年 | 72篇 |
2004年 | 69篇 |
2003年 | 63篇 |
2002年 | 74篇 |
2001年 | 51篇 |
2000年 | 50篇 |
1999年 | 48篇 |
1998年 | 88篇 |
1997年 | 67篇 |
1996年 | 79篇 |
1995年 | 60篇 |
1994年 | 59篇 |
1993年 | 58篇 |
1992年 | 33篇 |
1991年 | 33篇 |
1990年 | 30篇 |
1989年 | 59篇 |
1988年 | 42篇 |
1987年 | 46篇 |
1986年 | 47篇 |
1985年 | 28篇 |
1984年 | 33篇 |
1983年 | 25篇 |
1982年 | 24篇 |
1981年 | 23篇 |
1980年 | 26篇 |
1979年 | 22篇 |
1978年 | 16篇 |
1977年 | 27篇 |
1976年 | 16篇 |
1975年 | 18篇 |
1973年 | 11篇 |
1972年 | 12篇 |
1969年 | 9篇 |
排序方式: 共有2321条查询结果,搜索用时 0 毫秒
91.
Two patients with hairy cell leukemia with massive splenomegaly and severe pancytopenia were treated with recombinant alpha-A interferon (IFN-alpha-2a). There was no significant response to a trial of IFN- alpha-2a (11 and 20 weeks) with respect to blood counts or spleen size. Subsequent treatment with 2'-deoxycoformycin (dCF) for 8 consecutive weeks (4 mg/m2/wk) resulted in normalization of spleen size and a normalization of peripheral blood counts and bone marrow in one patient. The second patient demonstrated a reduction in spleen size and improved blood counts following 9 weeks of dCF therapy but eventually became refractory. This demonstrates that dCF is non-cross-resistant with interferon and confirms the efficacy of dCF in nonsplenectomized patients. 相似文献
92.
93.
G. M. Moran B. Fletcher M. G. Feltham M. Calvert C. Sackley T. Marshall 《European journal of neurology》2014,21(10):1258-1267
Transient ischaemic attack (TIA) and minor stroke are characterized by short‐lasting symptoms; however, anecdotal and empirical evidence suggests that these patients experience ongoing cognitive/psychological impairment for which they are not routinely treated. The aims were (i) to investigate the prevalence and time course of fatigue, anxiety, depression, post‐traumatic stress disorder(PTSD) and cognitive impairment following TIA/minor stroke; (ii) to explore the impact on quality of life (QoL), change in emotions and return to work; and (iii) to identify where further research is required and potentially inform an intervention study. A systematic review of MEDLINE, EMBASE, PSYCINFO, CINAHL, the Cochrane libraries and the grey literature between January 1993 and April 2013 was undertaken. Literature was screened and data were extracted by two independent reviewers. Studies were included of adult TIA/minor stroke participants with any of the outcomes of interest: fatigue, anxiety, depression, PTSD, cognitive impairment, QoL, change in emotions and return to work. Random‐effects meta‐analysis pooled outcomes by measurement tool. Searches identified 5976 records, 289 were assessed for eligibility and 31 studies were included. Results suggest high levels of cognitive impairment and depression post‐TIA/minor stroke which decreased over time. However, frequencies varied between studies. Limited information was available on anxiety, PTSD and fatigue. Meta‐analysis revealed that the measurement tool administered influenced the prevalence of cognitive impairment: Mini‐Mental State Examination 17% [95% confidence interval (CI) 7, 26]; neuropsychological test battery 39% (95% CI 28, 50); Montreal Cognitive Assessment 54% (95% CI 43, 66). There is evidence to suggest that TIA/minor stroke patients may experience residual impairments; however, results should be interpreted with caution because of the few high quality studies. Notwithstanding, it is important to raise awareness of potential subtle but meaningful residual impairments. 相似文献
94.
95.
96.
97.
98.
目的探讨经关节入路微创钢板固定(MIPPO)技术治疗股骨远端C型骨折的临床疗效。方法2002年4月~2005年2月,应用MIPPO技术治疗股骨远端C型骨折14例,按AO/ASIF分类:C1型3例,C2型6例,C3型5例。先行关节内骨折切开复位、松质骨螺钉固定,再行髁上部分骨折间接复位、经关节内切口插入髁支撑钢板或LISS钢板桥接固定骨折。结果12例患者获得10~32个月(平均18.4个月)随访,骨折均获愈合,愈合时间10周~12个月,平均4.6个月。按Kolmert和Wulff的评价标准:优4例,良5例,可2例,差1例,优良率为75%。结论应用MIPPO技术治疗股骨远端C型骨折实现了微创操作,具有创伤小、软组织干扰少、骨折愈合快等优点,疗效满意。 相似文献
99.
Elrod JW Calvert JW Gundewar S Bryan NS Lefer DJ 《Proceedings of the National Academy of Sciences of the United States of America》2008,105(32):11430-11435
Endothelial NOS (eNOS)-derived NO has long been considered a paracrine signaling molecule only capable of affecting nearby cells because of its short half-life in blood and relatively limited diffusion distance in tissues. To date, no studies have demonstrated that endogenously generated NO possesses a clearly defined endocrine function. Therefore, we evaluated whether enzymatic generation of NO in the heart is capable of modulating remote physiological actions and cell signaling. Mice with cardiac-specific overexpression of the human eNOS gene (CS-eNOS-Tg) were used to address this hypothesis. Cardiac-specific eNOS overexpression resulted in significant increases in nitrite, nitrate, and nitrosothiols in the heart, plasma, and liver. To examine whether the increase in hepatic NO metabolites could modulate cytoprotection, we subjected CS-eNOS-Tg mice to hepatic ischemia-reperfusion (I/R) injury. CS-eNOS-Tg mice displayed a significant reduction in hepatic I/R injury (4.2-fold reduction in the aminotransferase and a 3.5-fold reduction in aspartate aminotransferase) compared with WT littermates. These findings demonstrate that endogenously derived NO is transported in the blood, metabolized in remote organs, and mediates cytoprotection in the setting of I/R injury. This study presents clear evidence for an endocrine role of NO generated endogenously from eNOS and provides additional evidence for the profound cytoprotective actions of NO in the setting of I/R injury. 相似文献
100.
Inhibition of apoptosis by hyperbaric oxygen in a rat focal cerebral ischemic model. 总被引:45,自引:0,他引:45
Dali Yin Changman Zhou Ikuyo Kusaka John W Calvert Andrew D Parent Anil Nanda John H Zhang 《Journal of cerebral blood flow and metabolism》2003,23(7):855-864
The hypothesis was tested that hyperbaric oxygen therapy (HBO) reduced brain infarction by preventing apoptotic death in ischemic cortex in a rat model of focal cerebral ischemia. Male Sprague-Dawley rats were subjected to middle cerebral artery occlusion/reperfusion (MCAO/R) and subsequently were exposed to HBO (2.5 atmospheres absolute) for 2 h, at 6 h after reperfusion. Rats were killed and brain samples were collected at 24, 48, 72 h, and 7 days after reperfusion. Neurologic deficits, infarction area, and apoptotic changes were evaluated by clinical scores, 2,3,7-triphenyltetrazolium chloride staining, caspase-3 expression, DNA fragmentation assay, and terminal deoxynucleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate-biotin nick end labeling (TUNEL)-hematoxylin and eosin (H&E) costaining. In MCAO/R without HBO treatment animals, DNA fragmentation was observed in injured cortex at 24, 48, and 72 h but not in samples at 7 days after reperfusion. Double labeling of brain slides with NeuN and caspase-3 demonstrated neurons in the injured cortex labeled with caspase-3. TUNEL+H&E costaining revealed morphologic apoptotic changes at 24, 48, and 72 h after reperfusion. Hyperbaric oxygen therapy abolished DNA fragmentation and reduced the number of TUNEL-positive cells. Hyperbaric oxygen therapy reduced infarct area and improved neurologic scores at 7 days after reperfusion. One of the molecular mechanisms of HBO-induced brain protection is to prevent apoptosis, and this effect of HBO might preserve more brain tissues and promote neurologic functional recovery. 相似文献